Refer a Patient: Cancer Immunotherapy Toxicity Evaluation (CITE) Program

Contact Us

To refer a patient who resides in the United States, you have two options:

1. Use MD Link, our secure portal for physicians.
2. Download our referral form, complete it and fax it to the clinic.

Download referral form

If you need assistance, please give us a call.

When to refer a patient to the Cancer Immunotherapy Toxicity Evaluation (CITE) Program

Patients on an immunotherapy regimen for cancer who are experiencing complex or treatment-resistant side effects are eligible for referral.

This includes patients with:

• Side effects that require an interruption of immunotherapy treatment
• Side effects that make them interested in or eligible for clinical trials run by CITE
• Immune-related toxicities that resist standard treatment
• Chronic immune-related toxicities that could benefit from the CITE Program’s team of subspecialists
• Interest in obtaining second opinions or more information on managing side effects from immunotherapies

Immunotherapy side effects may not appear until a patient is several weeks into treatment, and some persist after the treatment course is complete. CITE doctors work in partnership with referring providers and can provide care until side effects resolve or are stabilized.